H. Rúmke

Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children.

A. van Belkum, H. Verbrugh, R. de Groot, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

No epidemiological evidence for infant vaccinations to cause allergic disease

N. Nagelkerke, W. Eden, H. Rúmke, 2004 .

Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands.

A. V. van Loon, H. G. van der Avoort, H. Rúmke, 2001, The Journal of infectious diseases.

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.

M. Lehtinen, J. Richardus, B. Spiessens, 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

The nuclear symptom of schizophrenia and the praecoxfeeling

H. Rúmke, J. Neeleman, 1990, History of psychiatry.

Community-based evaluation survey of immunizations in Burkina Faso.

H. Rúmke, M. Schlumberger, V. Schwoebel, 1992, Bulletin of the World Health Organization.

Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children

H. Verbrugh, H. Verbrugh, A. Belkum, 2004, The Lancet.

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

H. D. de Melker, M. Postma, L. van Alphen, 2004, Vaccine.

Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.

H. Rúmke, K. Hoppenbrouwers, A. Malfroot, 2011, Vaccine.

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.

E. Emini, W. Gruber, J. Pénzes, 2011, Vaccine.

Immunogenicity and safety of monovalent P1.7h,4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

L. van Alphen, L. Alphen, R. de Groot, 2000 .